Physician Assistant Advisory Committee
Alerts
Page Content
|
Scam Alert
The Division of Consumer Affairs (Division) is warning all licensed professionals about individuals impersonating New Jersey Division of Consumer Affairs (DCA) investigators, Drug Enforcement Administration (DEA) agents, DEA investigators, New Jersey Drug Control Unit investigators, Federal Bureau of Investigation (FBI) investigators, and other law enforcement personnel, as part of an extortion scheme. The impersonators are contacting licensees by telephone or letter, stating that they are the subject of an investigation. The callers are demanding money to clear up the matter, or threatening to revoke the individual's license. Please be advised that the Division of Consumer Affairs will not contact licensees by telephone to discuss investigations or demand money. Anyone receiving a telephone call from a person purporting to be any of the above mentioned individuals seeking money, should refuse the demand. We encourage you to report the call to the Federal Trade Commission (FTC) at
ReportFraud.ftc.gov. You may also report the call to the Division at
AskConsumerAffairs@lps.state.nj.us.
|
|
Electronic Prescribing of Controlled Substances (EPCS) for a Practitioner
On January 7, 2013 the Board of Pharmacy and Drug Control Unit adopted rules to allow prescribers to issue Schedule II controlled substances prescriptions electronically in accordance with federal requirements. New Jersey practitioners and pharmacies can utilize EPCS for all patient prescriptions.
View EPCS Information |
|
Physician Issuance of Multiple Prescriptions for Schedule II Controlled Substances
The New Jersey Division of Consumer Affairs is re-issuing the following guidance regarding the issuance of multiple prescriptions of a Schedule II controlled dangerous substance by a physician to a patient
View Guidance |
|
Information About the New NJ PMP Law.
In July, Senate Bill 1998 was signed into law (P.L.2015, c.74) which substantially revises the scope and expands the capabilities of the New Jersey Prescription Monitoring Program (NJPMP). The Division of Consumer Affairs is tasked with implementing the new law, which takes effect on November 1, 2015.
View Notice |
|
Student-Athlete Cardiac Assessment Professional Development Module
(PD module)
The New Jersey Department of Education (NJDOE) is pleased to announce the availability of the
Student-Athlete Cardiac Assessment professional development module (PD module) required by the
Scholastic Student-Athlete Safety Act (P.L. 2013, c.71). Physicians, advanced practice nurses and physician assistants are required to complete the PD module before performing any student-athlete pre-participation physical examination prior to the first official practice of the athletic season starting with the 2015-16 school year. The legislation required the development of the PD module to increase the assessment skills of the health care providers who perform student-athlete physical examinations and screenings. The PD module can be found
here. Additionally, the legislation
requires that the American Academy of Pediatrics, the New Jersey Academy of Family Physicians, the American Heart Association, the American College of Cardiology, the Athletic Trainer’s Society of New Jersey, the State Board of Medical Examiners, the New Jersey State Board of Nursing and the New Jersey State Society of Physician Assistants to post the link to the PD module on their respective websites and also the link to the
Sudden Cardiac Death in Young Athletes pamphlet. If you have any questions, please direct them
here. |
Last Modified: 3/20/2024 9:36 AM
